![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
01 BBI ENZYMES SA (PTY) LTD Cape Town ZA (1)
01 Proteases, Trypsin (product code 201553); Chymotrypsin (product code 031110); Mixtures of Trypsin/Chymotrypsin (product codes 161903 and 161905); Chymotrypsinogen (product code 031120); Mixture of Purified Protease Concentrate/Chymotrypsin (product code 1 (1)
01 South Africa (1)
01 Valid (1)
20
Bbi Enzymes Sa (pty) Ltd Cape Town Za, based in United Kingdom, is a pharmaceutical company.
One of their significant offerings is Proteases, Trypsin (product code 201553); Chymotrypsin (product code 031110); Mixtures of Trypsin/Chymotrypsin (product codes 161903 and 161905); Chymotrypsinogen (product code 031120); Mixture of Purified Protease Concentrate/Chymotrypsin (product code 1, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2001-209 - Rev 03
This TSE Type CEP, issued on December 18, 2013, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.